The Trustees of Columbia University in the City of New York
Welcome,         Profile    Billing    Logout  
 22 Trials 
26 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ali, Syed
SCALP2, NCT05914805: A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss

Recruiting
3
726
Europe, US
Clascoterone 5% solution, CB-03-01 5% solution, Vehicle solution, Vehicle
Cassiopea SpA, Ergomed PLC, Pharmapace Inc, Canfield Scientific Inc., ICON Clinical Research
Alopecia, Androgenetic
08/24
03/25
NCT03376477: Allogeneic Myeloma GM-CSF Vaccine With Lenalidomide in Multiple Myeloma Patients in Complete or Near Complete Remission

Active, not recruiting
2
54
US
GM-CSF vaccine, GVAX, Lenalidomide, Revlimid, Prevnar13, pneumococcal vaccine, Placebo Prevnar13, Placebo GM-CSF Vaccine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Celgene, Aduro Biotech, Inc.
Multiple Myeloma
01/24
12/24
NCT05772520: The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis

Completed
2
82
US
TLL018 tablets, TLL018 Placeboes
Hangzhou Highlightll Pharmaceutical Co., Ltd
Plaque Psoriasis
12/24
12/24
CAMEO, NCT04076813: Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry

Recruiting
N/A
4000
US
Chiesi USA, Inc., Duke University
Myocardial Infarction
10/24
10/24
Kirtane, Ajay
RADIANCE-HTN, NCT02649426: A Study of the ReCor Medical Paradise System in Clinical Hypertension

Active, not recruiting
N/A
282
Europe, US
The Paradise® Renal Denervation Ultrasound System, renal denervation, Sham Procedure, renal angiogram
ReCor Medical, Inc.
Hypertension, Vascular Diseases
09/20
05/25
RADIANCE-II, NCT03614260: The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension

Active, not recruiting
N/A
225
Europe, US
Paradise Renal Denervation System, Renal Angiogram, Renal Denervation
ReCor Medical, Inc.
Hypertension, Vascular Diseases, Cardiovascular Diseases
12/22
07/27
CAMEO, NCT04076813: Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry

Recruiting
N/A
4000
US
Chiesi USA, Inc., Duke University
Myocardial Infarction
10/24
10/24
NCT05372679: REDUCED 1 - Renal Denervation Using Ultrasonic Catheter EmitteD Energy Study /

Active, not recruiting
N/A
25
US
Renal denervation
SoniVie Inc.
Uncontrolled Stage 2 Hypertension
12/25
12/25
VITALYST EFS, NCT06132568: VITALYST Early Feasibility Study in High-Risk PCI Patients

Active, not recruiting
N/A
15
Europe, US
VITALYST System, Percutaneous Mechanical Circulatory Support
Boston Scientific Corporation
High-risk Percutaneous Coronary Intervention, Heart Disease, Coronary
10/24
01/25
COSIRA-II, NCT05102019: Efficacy of the COronary SInus Reducer in Patients with Refractory Angina II

Recruiting
N/A
380
Canada, US
Arm 1: treatment with Neovasc Reducer, Arm 2 (control): Implantation procedure with no device implanted, Arm 3 (unblinded, non-randomized): Single arm registry
Neovasc Inc., Shockwave Medical, Inc.
Refractory Angina
06/25
12/28
ECLIPSE, NCT03108456: Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The Trial

Active, not recruiting
N/A
2005
US
Orbital Atherectomy, Balloon
Abbott Medical Devices, Cardiovascular Research Foundation, New York
Coronary Artery Disease, Ischemic Heart Disease, Non ST Segment Elevation Myocardial Infarction
06/24
06/25
US GPS, NCT06297291: Global Paradise System US Post Approval Study

Recruiting
N/A
1000
US
Paradise Ultrasound Renal Denervation Treatment, Paradise Ultrasound RDN
ReCor Medical, Inc.
Hypertension, Cardiovascular Diseases, Vascular Diseases
09/26
07/31
THRIVE, NCT06559891: - THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

Recruiting
N/A
261
US
TIVUS™ Renal Denervation System, Renal Denervation, Sham
SoniVie Inc., NAMSA, European Cardiovascular Research Center
Hypertension
10/25
08/28
ALL-RISE, NCT05893498: Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment

Recruiting
N/A
1924
Europe, Japan, US, RoW
FFRangio, FFR or NHPR, FFR, iFR RFR, dPR, Pd/Pa
CathWorks Ltd., Cardiovascular Research Foundation, New York
Percutaneous Coronary Intervention
12/24
12/24
MAGICAL ISR, NCT05908331: MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

Recruiting
N/A
492
US
Sirolimus Drug Coated Balloon, Plan balloon Angioplasty (POBA)
Concept Medical Inc., Cardiovascular Research Foundation, New York
In-Stent Restenosis, Cardiovascular Diseases, Coronary Artery Disease
09/25
02/28
TRIO CAP, NCT05017935: RADIANCE Continued Access Protocol

Active, not recruiting
N/A
300
US
Renal Denervation
ReCor Medical, Inc.
Hypertension, Hypertension, Resistant to Conventional Therapy, Vascular Diseases, Cardiovascular Diseases
12/28
12/28
Askanase, Anca D
AMETHYST, NCT05531565 / 2020-000727-40: A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

Recruiting
2/3
474
Europe, Canada, Japan, US, RoW
Litifilimab, BIIB059, Placebo
Biogen, Biogen Idec Research Limited
Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus
10/26
12/27
RESET-SLE, NCT06121297: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Recruiting
1/2
12
Europe, US
CABA-201
Cabaletta Bio
Systemic Lupus Erythematosus, Lupus Nephritis
12/27
12/27
NAIVE, NCT04726553: Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE

Recruiting
1
20
US
Anifrolumab, Medi 546, Standard of Care, azathioprine, methotrexate, mycophenolate mofetil, corticosteroids, antimalarials
Oklahoma Medical Research Foundation, NYU Langone Health, Yale University, Piedmont Heart Institute, Inc., Atlanta, GA, Columbia University
Systemic Lupus Erythematosus (SLE)
12/23
12/24
Musat, Claudia
PATENT-E, NCT05561114: Paclitaxel Coated Balloon for the Treatment of Chronic BEnigN STricture- Esophagus

Recruiting
3
198
US
GIE Medical ProTractX3 TTS DCB, Control
GIE Medical
Esophageal Stricture
07/25
12/29
PATENT-B, NCT05561127: Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel

Recruiting
3
171
US
GIE Medical ProTractX3 TTS DCB, Control
GIE Medical
Bowel; Stricture
09/24
03/29
RelayBranch, NCT03214601: Early Feasibility Study of the Thoracic Stent-Graft System

Active, not recruiting
N/A
30
US
penetrating atherosclerotic ulcer, aorta branch cardiovascular implant, Relay Branch System, system, endovascular graft, aortic aneurysm treatment
Bolton Medical
Thoracic Aorta Aneurysm, Aneurysm, Ruptured, Aortic Aneurysm
09/23
08/28
PERSEVERE, NCT05174767: - a Trial to Evaluate AMDS in Acute DeBakey Type I Dissection

Active, not recruiting
N/A
115
US
AMDS
Artivion Inc., Syneos Health
Acute Aortic Dissection
12/23
12/29
NCT06029660: AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion

Recruiting
N/A
180
Europe, US, RoW
IMPEDE-FX RapidFill Implants, EndoVascular Aneurysm Repair, EVAR
Shape Memory Medical, Inc., NAMSA
Aortic Aneurysm, Abdominal
06/27
06/31
Mendez, Juan
CAMEO, NCT04076813: Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry

Recruiting
N/A
4000
US
Chiesi USA, Inc., Duke University
Myocardial Infarction
10/24
10/24
Jordan, Brianna
NCT04724421: Expanded Access Protocol for Adults and Pediatric Patients With Sickle Cell Disease Who Have No Alternative Treatment Options

Available
N/A
US, RoW
Voxelotor, GBT440
Pfizer, Pfizer
Sickle Cell Disease
 
 

Download Options